X-BODY BioSciences Enters into R&D Partnership with Tanabe Research Labs U.S.A., Inc. to Generate Antibody Therapeutics for Autoimmune Disorders

X-BODY BioSciences Enters into R&D Partnership with Tanabe Research Labs U.S.A., Inc. to Generate Antibody Therapeutics for Autoimmune Disorders

WALTHAM, Mass., October 4, 2011 /Business Wire/ — X-BODY, Inc., a developer of monoclonal antibody therapeutics, today announced a partnership with Tanabe Research Laboratories U.S.A., Inc. (TRL). The companies will collaborate to identify therapeutic target epitopes and develop monospecific and/or bispecific antibodies to the identified therapeutic targets. X-BODY has developed an extremely diverse human antibody […]

Read More »
Tanabe Research Labs Enters R&D Partnership with Anaphore to Develop Novel Protein Pharmaceuticals For Autoimmune Disorders

Tanabe Research Labs Enters R&D Partnership with Anaphore to Develop Novel Protein Pharmaceuticals For Autoimmune Disorders

December 13th, 2010 San Diego, CA – (December 13th, 2010) – Tanabe Research Laboratories U.S.A. Inc., (TRL) announced today that it has entered into a partnership with Anaphore Inc. for the research and preclinical development of novel protein therapies for autoimmune diseases based on Anaphore’s proprietary Atrimerâ„¢ technology. TRL and Anaphore will generate novel trivalent […]

Read More »